Sheng-Huan Wei

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Idiopathic Pulmonary Fibrosis

Mechanical Ventilation

Top Venues

ERJ open research

Respirology case reports

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tang-Hsiu Huang, Sheng-Huan Wei, Hung-I Kuo, Hsin-Yu Hou, Chin-Wei Kuo, Yau-Lin Tseng, Sheng-Hsiang Lin, Chao-Liang Wu
Baseline Blood Levels of Mucin-1 Are Associated with Crucial On-Treatment Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Pirfenidone. Biomedicines 12 (2) (2024)
Tang-Hsiu Huang, Sheng-Huan Wei, Hung-I Kuo, Hsin-Yu Hou, Chin-Wei Kuo, Yau-Lin Tseng, Sheng-Hsiang Lin, Chao-Liang Wu
Baseline Blood Levels of Mucin-1 Are Associated with Crucial On-Treatment Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Pirfenidone. Biomedicines 12 (2) (2024)
Tang-Hsiu Huang, Sheng-Huan Wei, Li-Ting Huang, Hong-Ping Er, Yu-Ting Yu, Chung-Ta Lee, Yau-Lin Tseng, Chao-Liang Wu
Impact of computed tomographic patterns and extent on clinical management and outcomes of patients with organising pneumonia. ERJ open research 9 (1) (2023)
Tang-Hsiu Huang, Sheng-Huan Wei, Li-Ting Huang, Hong-Ping Er, Yu-Ting Yu, Chung-Ta Lee, Yau-Lin Tseng, Chao-Liang Wu
Impact of computed tomographic patterns and extent on clinical management and outcomes of patients with organising pneumonia. ERJ open research 9 (1) (2023)
Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Sheng-Huan Wei, Li-Ting Huang, Tang-Hsiu Huang
Chronic bronchiectasis complicated with benign jejuno-ileal pneumatosis intestinalis. Respirology case reports 10 (7) (2022)